# Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients

> **NCT03387774** · PHASE3 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 179 (actual)

## Conditions studied

- Oral Mucositis (Ulcerative) Due to Radiation

## Interventions

- **DRUG:** Cisplatin
- **RADIATION:** Intensity Modulated Radiation Therapy
- **DRUG:** Ulinastatin

## Key facts

- **NCT ID:** NCT03387774
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-30
- **Primary completion:** 2021-12-28
- **Final completion:** 2024-01-31
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2026-05-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03387774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03387774, "Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT03387774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*